GO:0051826 negative regulation of synapse structural plasticity: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051826 describes any process that stops, prevents, or reduces the frequency, rate or extent of synapse structural plasticity.
• Synapse structural plasticity is the activity-dependent remodeling of synaptic connections, including spine and bouton morphology, and its negative regulation is critical for circuit stability.
• Key molecular players include Cdc42 and its GEF Ephexin5, BDNF, cyclin Y, and ErbB1 receptor ligands that attenuate synaptic scaffolding proteins.
• Dysregulation of negative regulation of synapse structural plasticity is implicated in schizophrenia, affective disorders, and circadian remodeling defects.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in this process.
• Advanced methods such as activity-regulated splicing analysis, proteomics, and imaging are essential to dissect the molecular control of synapse structural plasticity.
Description
Synapse structural plasticity refers to the activity-dependent remodeling of synaptic connections, including changes in spine density, morphology, and bouton size, which underlies learning, memory, and circuit refinement. The Gene Ontology term GO:0051826, negative regulation of synapse structural plasticity, encompasses any process that stops, prevents, or reduces the frequency, rate or extent of this remodeling. This regulatory mechanism is essential for stabilizing neural circuits and preventing aberrant connectivity, and its disruption is linked to neuropsychiatric and neurological disorders. Researchers study this term to understand how molecular brakes on structural plasticity contribute to brain function and disease, and to identify therapeutic targets that modulate synaptic stability. The process involves a complex interplay of signaling molecules, cytoskeletal regulators, and activity-dependent gene expression programs.
negative regulation of synapse structural plasticity At A Glance
| GO ID | GO:0051826 |
|---|---|
| GO term | negative regulation of synapse structural plasticity |
| Ontology | biological_process |
| Synonym | down regulation of synapse structural plasticity; down-regulation of synapse structural plasticity; downregulation of synapse structural plasticity; inhibition of synapse structural plasticity |
| Major function | Restrains activity-dependent remodeling of synaptic structure, stabilizing neural circuits |
| Related processes | Regulation of synapse structural plasticity; synapse organization; actin cytoskeleton organization |
| Key regulators | Cdc42, Ephexin5, BDNF, cyclin Y, ErbB1 receptor ligands |
| Disease relevance | Schizophrenia, affective disorders, circadian rhythm disruption |
What Is GO:0051826?
GO:0051826 is defined as any process that stops, prevents, or reduces the frequency, rate or extent of synapse structural plasticity. In other words, it is the set of biological mechanisms that restrain the structural remodeling of synapses, such as limiting spine growth, promoting spine retraction, or stabilizing existing synaptic connections. This negative regulation can occur through molecular signals that inhibit actin dynamics, reduce scaffolding protein expression, or alter gene splicing in response to neuronal activity.
Why Is negative regulation of synapse structural plasticity Important in Cell Biology?
Negative regulation of synapse structural plasticity is crucial for maintaining stable neural circuits while allowing necessary plasticity. Without proper brakes on structural remodeling, synapses may become hyperplastic or unstable, leading to cognitive and emotional dysregulation. This process is implicated in schizophrenia, where synaptic hypothesis posits excessive pruning or destabilization, and in affective disorders where BDNF signaling modulates synaptic structure. Understanding the molecular mechanisms of this negative regulation can reveal therapeutic targets for neuropsychiatric diseases and inform strategies to promote circuit stability after injury or degeneration.
• Provides a molecular brake on activity-dependent spine growth, preventing runaway plasticity.
• Essential for circuit stabilization during development and learning.
• Dysregulation is linked to schizophrenia and other neuropsychiatric disorders.
• BDNF signaling, a key modulator, affects affective behaviors through synaptic regulation.
• Circadian structural plasticity in Drosophila is controlled by negative regulatory mechanisms.
• ErbB1 receptor ligands attenuate synaptic scaffolding proteins, influencing cortical development.
• Cyclin Y controls actin pathway to regulate spatial learning and memory flexibility.
• Activity-regulated alternative splicing contributes to negative regulation of synaptic structure.
• Targeting this process may offer therapeutic avenues for cognitive disorders.
• CRISPR models enable precise dissection of causal genes in this process.
What Happens During negative regulation of synapse structural plasticity?
Initiation by Activity-Dependent Signals
In simple terms: When neurons are highly active, they trigger signals that can put the brakes on synapse growth.
Negative regulation of synapse structural plasticity is often initiated by neuronal activity that activates signaling pathways to restrain structural remodeling. For example, activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization, but under certain conditions, negative regulators are engaged to limit this growth. BDNF signaling, which is activity-dependent, can also modulate synaptic structure and function, with distinct effects on affective behaviors. Activity-regulated alternative mRNA splicing produces variants of synaptic proteins that may act as dominant-negative regulators of plasticity.
Cytoskeletal Restraint via Actin Dynamics
In simple terms: The cell's internal skeleton is rearranged to stop synapses from changing shape.
Actin cytoskeleton dynamics are central to synapse structural plasticity, and negative regulation often involves inhibiting actin polymerization or promoting depolymerization. Cyclin Y regulates spatial learning and memory flexibility through distinct control of the actin pathway, acting as a negative regulator of structural plasticity. Ephexin5, a RhoGEF, modulates Cdc42 activity to drive synapse growth and stabilization, but its negative regulation can reverse these effects. ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins GRIP1 and SAP97, which are essential for stabilizing synaptic structure, thereby negatively regulating plasticity.
Transcriptional and Splicing Control
In simple terms: The cell changes which proteins it makes to lock synapses in place.
Long-term negative regulation of synapse structural plasticity requires changes in gene expression, including alternative splicing. Neuronal activity-regulated alternative mRNA splicing generates protein isoforms that can inhibit synaptic remodeling. For instance, splicing of transcripts encoding synaptic proteins may produce variants that lack domains required for plasticity, thus acting as negative regulators. This transcriptional and post-transcriptional control ensures that structural changes are limited in duration and extent.
Circadian and Homeostatic Regulation
In simple terms: The body's clock and overall activity levels help keep synapse changes in check.
Circadian structural plasticity drives remodeling of E cell output in Drosophila, and negative regulation of this process ensures proper timing of synaptic changes. Homeostatic mechanisms also prevent excessive plasticity by scaling synaptic strength and structure. For example, BDNF signaling can have opposing effects on synaptic structure depending on the context, contributing to homeostatic regulation of affective behaviors. These regulatory layers ensure that synapse structural plasticity is appropriately constrained.
Key Genes Involved in GO:0051826 negative regulation of synapse structural plasticity
The following genes and proteins have been experimentally implicated in the negative regulation of synapse structural plasticity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cdc42 | Rho GTPase regulating actin dynamics; activity-dependent regulation by Ephexin5 drives synapse growth and stabilization | Key node in bidirectional control of structural plasticity |
| Ephexin5 | RhoGEF that activates Cdc42; its regulation modulates synapse growth | Direct regulator of Cdc42 in activity-dependent plasticity |
| BDNF | Neurotrophin that modulates synaptic structure and function; affects affective behaviors | Implicated in negative regulation of plasticity in mood disorders |
| Cyclin Y | Regulates actin pathway; controls spatial learning and memory flexibility | Negative regulator of structural plasticity in hippocampus |
| ErbB1 | Receptor tyrosine kinase; ligands attenuate synaptic scaffolding proteins GRIP1 and SAP97 | Negatively regulates expression of scaffolding proteins in developing neocortex |
| GRIP1 | Synaptic scaffolding protein; its attenuation reduces synaptic stability | Target of ErbB1 signaling in negative regulation |
| SAP97 | Synaptic scaffolding protein; its attenuation reduces synaptic stability | Target of ErbB1 signaling in negative regulation |
| GRIN2A | NMDA receptor subunit; activity-dependent signaling upstream of plasticity regulation | Involved in synaptic plasticity and schizophrenia |
| GRIN2B | NMDA receptor subunit; activity-dependent signaling upstream of plasticity regulation | Involved in synaptic plasticity and schizophrenia |
| ARC | Activity-regulated cytoskeleton-associated protein; mediates synaptic weakening | Immediate early gene involved in negative regulation of plasticity |
| Homer1 | Scaffolding protein at excitatory synapses; regulates mGluR signaling | Modulates structural plasticity |
| Shank3 | Postsynaptic scaffolding protein; mutations linked to autism and schizophrenia | Regulates synapse stability |
| DISC1 | Schizophrenia risk factor; regulates synaptic plasticity and structure | Implicated in negative regulation of plasticity |
| Neuregulin1 | ErbB1 ligand; attenuates synaptic scaffolding proteins | Negative regulator of synaptic structure |
| Kalirin-7 | RhoGEF that regulates spine morphogenesis | Potential negative regulator via actin dynamics |
| Rac1 | Rho GTPase regulating actin; involved in spine plasticity | Downstream of Ephexin5 and Cdc42 |
| Cofilin | Actin depolymerizing factor; mediates spine shrinkage | Effector of negative regulation |
| LIMK1 | Kinase that inhibits cofilin; promotes actin stabilization | Regulates spine morphology |
How Is negative regulation of synapse structural plasticity Regulated?
The negative regulation of synapse structural plasticity is itself tightly regulated by upstream signaling pathways. BDNF signaling, through TrkB receptors, can activate or inhibit structural plasticity depending on the cellular context and developmental stage. Activity-dependent alternative splicing of genes encoding synaptic proteins provides a rapid mechanism to switch between plasticity-promoting and plasticity-restraining isoforms. Circadian clocks also regulate structural plasticity in Drosophila, ensuring that remodeling occurs at appropriate times. Additionally, ErbB1 receptor signaling attenuates the expression of synaptic scaffolding proteins GRIP1 and SAP97, thereby negatively regulating structural stability. These regulatory layers ensure that synapse structural plasticity is balanced with circuit stability.
negative regulation of synapse structural plasticity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BDNF | Affective disorders, depression | Conditional knockout mouse, BDNF overexpression |
| DISC1 | Schizophrenia | Knockout rat, point mutation knock-in |
| ErbB1 | Schizophrenia, cortical development | ErbB1 knockout mouse, ligand overexpression |
| Cyclin Y | Cognitive flexibility, learning deficits | Cyclin Y knockout mouse, overexpression |
| Cdc42 | Neurodevelopmental disorders | Cdc42 knockout, point mutation (GTPase-deficient) |
Schizophrenia
The synaptic hypothesis of schizophrenia version III posits that excessive synaptic pruning or destabilization contributes to disease onset, and negative regulation of synapse structural plasticity is a key protective mechanism. Genetic and environmental factors that impair this negative regulation may lead to aberrant connectivity and psychotic symptoms. Molecules such as DISC1, Neuregulin1, and ErbB1 signaling have been implicated in both schizophrenia and the regulation of synaptic structure.
Affective Disorders
BDNF signaling, a major modulator of synaptic structure, is critically involved in affective behaviors such as depression and anxiety. Negative regulation of synapse structural plasticity by BDNF may be disrupted in mood disorders, leading to maladaptive synaptic remodeling. Understanding how BDNF and its downstream effectors restrain structural plasticity could inform novel antidepressant strategies.
Circadian Rhythm Disruption
Circadian structural plasticity drives remodeling of E cell output in Drosophila, and negative regulation ensures proper timing of these changes. Disruption of this negative regulation may lead to circadian rhythm abnormalities and associated cognitive deficits. This highlights the importance of temporal control in synapse structural plasticity.
From negative regulation of synapse structural plasticity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Cdc42 enhance synapse structural plasticity? | Cdc42 knockout or point mutation (constitutively active/inactive) |
| How does Ephexin5 regulate Cdc42 in vivo? | Ephexin5 knockout mouse, tagged knock-in for localization |
| What is the role of BDNF in negative regulation of structural plasticity? | BDNF conditional knockout, overexpression, or point mutation (TrkB binding) |
| Does cyclin Y control actin dynamics to limit spine growth? | Cyclin Y knockout, overexpression, or point mutation |
| How does ErbB1 signaling attenuate GRIP1/SAP97? | ErbB1 knockout, ligand overexpression, GRIP1/SAP97 tagged knock-in |
| What is the impact of circadian clock genes on structural plasticity? | Clock gene knockout in Drosophila, overexpression |
How to Study the negative regulation of synapse structural plasticity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Two-photon microscopy | Spine dynamics in live animals | Longitudinal imaging of structural plasticity |
| Confocal imaging | Spine density and morphology | Quantification of structural changes after genetic manipulation |
| Electron microscopy | Synaptic ultrastructure | Ultrastructural analysis of synapse stability |
| RNA-seq | Alternative splicing and gene expression | Identification of activity-regulated splicing events |
| Proteomics | Protein expression levels | Quantification of scaffolding proteins like GRIP1/SAP97 |
| Western blot | Protein abundance | Validation of proteomic findings |
| Behavioral assays | Learning and memory | Assessment of cognitive flexibility |
| Electrophysiology | Synaptic transmission and plasticity | Functional correlate of structural changes |
Imaging of Synapse Structure
Two-photon microscopy, confocal imaging, and electron microscopy are used to visualize spine density, morphology, and synaptic ultrastructure in fixed or live tissue. These methods allow quantification of structural plasticity and its negative regulation in response to genetic or pharmacological manipulations.
Activity-Regulated Splicing Analysis
RNA sequencing and RT-PCR are employed to detect activity-dependent alternative splicing events in genes encoding synaptic proteins. This reveals how splicing variants contribute to negative regulation of structural plasticity.
Proteomics and Western Blotting
Mass spectrometry-based proteomics and immunoblotting quantify expression levels of synaptic scaffolding proteins such as GRIP1 and SAP97, which are attenuated by ErbB1 signaling to negatively regulate plasticity.
Behavioral Assays
Spatial learning and memory flexibility tasks, such as the Morris water maze or fear conditioning, assess the functional consequences of manipulating negative regulators of structural plasticity, as demonstrated for cyclin Y and BDNF.
How CRISPR Can Be Used to Study GO:0051826 negative regulation of synapse structural plasticity
Knockout
CRISPR-Cas9 knockout of genes such as Cdc42, Ephexin5, or cyclin Y can be used to test whether they are required for negative regulation of synapse structural plasticity. Loss-of-function models may exhibit increased spine density or enhanced structural plasticity, revealing the gene's role as a brake.
Point Mutation
Point mutations can be introduced to dissect specific domains or phosphorylation sites. For example, a GTPase-deficient Cdc42 mutant can clarify whether its activity is necessary for restraining structural plasticity. Similarly, point mutations in BDNF can separate its effects on structural versus functional plasticity.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-tagged Ephexin5 or cyclin Y) allows visualization of their localization and dynamics in live neurons. This helps determine where and when these negative regulators act to limit structural plasticity.
Overexpression
Overexpression of candidate negative regulators, such as cyclin Y or Ephexin5, can test whether increasing their levels is sufficient to reduce synapse structural plasticity. This approach can also be used to rescue phenotypes in knockout backgrounds.
How EDITGENE Supports negative regulation of synapse structural plasticity Research
Researchers studying negative regulation of synapse structural plasticity-related genes often need to determine whether a candidate gene is causally involved in restraining synaptic remodeling. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional dissection of these regulatory mechanisms.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of synapse structural plasticity research.
Frequently Asked Questions About negative regulation of synapse structural plasticity
What is GO:0051826?
GO:0051826 is the Gene Ontology term for negative regulation of synapse structural plasticity, defined as any process that stops, prevents, or reduces the frequency, rate or extent of synapse structural plasticity.
What genes are involved in negative regulation of synapse structural plasticity?
Key genes include Cdc42, Ephexin5, BDNF, cyclin Y, ErbB1, GRIP1, and SAP97, among others.
How is synapse structural plasticity negatively regulated?
It is negatively regulated by activity-dependent signaling, actin cytoskeleton restraint, alternative splicing, and circadian/homeostatic mechanisms.
What diseases are associated with dysregulation of this process?
Schizophrenia, affective disorders, and circadian rhythm disruptions have been linked to impaired negative regulation of synapse structural plasticity.
What methods are used to study negative regulation of synapse structural plasticity?
Common methods include imaging (two-photon, confocal, electron microscopy), RNA-seq for splicing, proteomics, behavioral assays, and electrophysiology.
How can CRISPR be used to study this process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in negative regulation of synapse structural plasticity.
What is the role of BDNF in this process?
BDNF signaling modulates synaptic structure and can negatively regulate structural plasticity in the context of affective behaviors.
What is the role of Cdc42 in synapse structural plasticity?
Cdc42 is a Rho GTPase regulated by Ephexin5 that drives synapse growth and stabilization; its negative regulation restrains structural plasticity.
How does cyclin Y affect structural plasticity?
Cyclin Y regulates the actin pathway to control spatial learning and memory flexibility, acting as a negative regulator of structural plasticity.
What is the synaptic hypothesis of schizophrenia?
It posits that excessive synaptic pruning or destabilization contributes to schizophrenia, implicating negative regulation of synapse structural plasticity as a protective mechanism.
Conclusion
GO:0051826, negative regulation of synapse structural plasticity, is a critical biological process that restrains activity-dependent remodeling of synaptic connections. Its molecular underpinnings involve a complex interplay of Rho GTPases, neurotrophins, scaffolding proteins, and activity-regulated splicing. Dysregulation of this process is linked to major neuropsychiatric disorders, making it a compelling target for therapeutic intervention. CRISPR-based models and advanced imaging and omics methods are essential tools for dissecting its mechanisms and translating findings into clinical advances.
References
- 1. Howes OD et al.. 2023. The synaptic hypothesis of schizophrenia version III: a master mechanism.. Mol Psychiatry 28(5):1843-1856 PMID: 37041418
- 2. Petshow S et al.. 2025. Activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization.. Sci Adv 11(13):eadp5782 PMID: 40138406
- 4. Hermey G et al.. 2017. Neuronal activity-regulated alternative mRNA splicing.. Int J Biochem Cell Biol 91(Pt B):184-193 PMID: 28591617
- 5. Duhart JM et al.. 2020. Circadian Structural Plasticity Drives Remodeling of E Cell Output.. Curr Biol 30(24):5040-5048.e5 PMID: 33065014
- 6. Ninan I. 2014. Synaptic regulation of affective behaviors; role of BDNF.. Neuropharmacology 76 Pt C(0 0):684-95 PMID: 23747574
- 7. Seo J et al.. 2023. Cyclin Y regulates spatial learning and memory flexibility through distinct control of the actin pathway.. Mol Psychiatry 28(3):1351-1364 PMID: 36434054
- 8. Yokomaku D et al.. 2005. ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins, GRIP1 and SAP97, in developing neocortex.. Neuroscience 136(4):1037-47 PMID: 16226841
